Spatial Strand Capping for Sequence-Controlled Polynucleotide Arrays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Enzymatic polynucleotide synthesis lacks precise control over the base-by-base sequence due to template-independent polymerases adding nucleotides in an unregulated manner, leading to challenges in creating polynucleotides with specific sequences, especially in high-throughput and parallel synthesis applications.

Innovation Solution

Spatially addressable control of polynucleotide extension on an array by selectively removing 3′ blocking groups from polynucleotide strands using techniques such as electrochemistry, localized basic environments, or photocleavable groups, allowing for the synthesis of multiple polynucleotides with different sequences on the same array.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If template-independent polymerase is used for enzymatic polynucleotide synthesis, then the synthesis can be performed in aqueous environment without toxic chemicals and can create longer polynucleotides, but the base-by-base sequence control is lost and random sequences are created

Engineering Contradiction:
Improvesynthesis environment safetyVSAvoidsequence control precision
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent applies local quality by creating spatially distinct regions on the array where blocking groups are selectively removed. Different locations on the array have different fates: some locations have blocking groups removed allowing nucleotide addition, while others retain blocking groups preventing addition. This spatial differentiation enables precise control over which polynucleotide strands are extended at each synthesis cycle.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent segments the polynucleotide synthesis process into discrete spatial locations on an array, where each location can be independently controlled. By dividing the synthesis array into multiple addressable locations and selectively removing blocking groups at specific locations, the system achieves parallel synthesis of multiple polynucleotides with different sequences while maintaining precise base-by-base control.

Inventive Principle:
Principle #1Segmentation

2Adaptability or versatility

If multiple types of nucleotides are provided to template-independent polymerase, then sequence diversity is increased, but random sequences are created instead of controlled sequences

Engineering Contradiction:
Improvesequence diversityVSAvoidsequence specificity
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent applies preliminary action by pre-attaching blocking groups to the 3' ends of polynucleotide strands before synthesis begins. These blocking groups prevent nucleotide addition until selectively removed. By controlling which blocking groups are removed and when, the system ensures that only specific nucleotides are added at specific locations, achieving both sequence diversity and precision.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The blocking group acts as an intermediary element that mediates between the template-independent polymerase and the nucleotide addition process. The blocking group temporarily prevents nucleotide addition, and its selective removal controls when and where addition occurs. This intermediary mechanism enables precise sequence control even when multiple nucleotide types are available.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If blocking groups are added to control nucleotide addition, then sequence precision is improved, but the synthesis process becomes more complex

Engineering Contradiction:
Improvebase-by-base sequence controlVSAvoidsynthesis process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical control systems with a simpler chemical blocking mechanism. Instead of using complex physical or enzymatic control systems to regulate nucleotide addition, the system uses chemical blocking groups that can be selectively removed by controlled chemical or physical means (such as UV irradiation or chemical treatment). This substitution simplifies the overall system while maintaining precise control.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Productivity

If selective removal of blocking groups is performed at multiple locations, then parallel synthesis of multiple polynucleotides is enabled, but control and coordination becomes more difficult

Engineering Contradiction:
Improvesynthesis throughputVSAvoidspatial control complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent adds a spatial dimension to the synthesis control by using an array-based system where different locations can be independently controlled. Instead of controlling synthesis in a single dimension (time), the system uses two dimensions (space and time) by selectively removing blocking groups at different locations at different times. This enables parallel synthesis while maintaining simple control through spatial addressing.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the efficient, parallel synthesis of polynucleotides with arbitrary sequences, improving scalability and throughput by controlling nucleotide incorporation at specific locations, overcoming the limitations of unregulated enzymatic synthesis.

Implementation Method 1

Enzymatic polynucleotide synthesis is performed with a template-independent polymerase such as terminal deoxynucleotide transferase (TdT) rather than a series of chemical reactions

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 2

The localized basic environment may be created by electrochemistry. An electrode, such as a microelectrode integrated into the array, may cause deacylation in proximity to the electrode by generating a negative voltage that removes the acyl groups and produces free 3'-OH groups

Methodology Applied
Scientific EffectElectrochemical deacylation: Electrolysis

Data Source

PatentUS20250333773A1Spatial control of polynucleotide synthesis by strand capping
Publication Date: 2025.10.30 MICROSOFT TECHNOLOGY LICENSING LLC
  • US20250333773A1 patent drawing
  • US20250333773A1 patent drawing
  • US20250333773A1 patent drawing

AI summary

Enzymatic polynucleotide synthesis with a template-independent polymerase is used to create multiple polynucleotides having different, arbitrary sequences on the surface of an array. The array provides a spatially-addressable substrate for solid-phase synthesis. Blocking groups are attached to the 3′ ends of polynucleotides on the array. Prior to polynucleotide extension, the blocking groups are removed at a selected location on the array. In an implementation, the blocking groups are acyl groups removed with a negative voltage created at an electrode. The array is then incubated with the polymerase and a single species of nucleotide. Nucleotides are incorporated onto the 3′ ends of the polynucleotides without blocking groups. Washing removes the polymerase and free nucleotides. To create polynucleotides with different sequences at different locations on the array, the location where the blocking groups are removed and the species of nucleotide may be changed during repeated cycles of synthesis.